InHealth will soon launch what the company is calling the UK's first relocatable radioligand therapy service for cancer care.
InHealth said its existing PET-CT service already supports over 20,000 UK cancer patients each year through both mobile and static sites. The company said the relocatable facility to be offered with its new radioligand service will provide additional capacity to existing sites that offer this kind of care from acute hospitals and static locations.
It also aims to support patients in new and harder-to-reach locations, addressing geographic barriers these patients face.
